Synspira Therapeutics Receives Orphan Designation for SNSP113 for the Treatment of Cystic Fibrosis in the European Union April 10, 2019https://www.prnewswire.com/news-releases/synspira-therapeutics-receives-orphan-designation-for-snsp113-for-the-treatment-of-cystic-fibrosis-in-the-european-union-300829745.html
